Securities Code: 002898
Securities Abbreviation: Sailong Delisting
Announcement Number: 2026-072
Sailong Pharmaceutical Group Co., Ltd.
Announcement on Risk Warning for the First Day of the Company's Stock Entering the Delisting Arrangement Period
The Company and all members of its Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and there are no false records, misleading statements, or major omissions.
Special Risk Warning:
-
The shares of Sailong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") will be delisted on the next trading day after the delisting arrangement period ends, and the Company's shares will be terminated from listing.
-
The Company's shares will resume trading and enter the delisting arrangement period on June 26, 2026. The delisting arrangement period will last for fifteen trading days, with the expected last trading day being July 16, 2026. Investors are requested to invest prudently and pay attention to risks.
-
During the trading period of the Company's shares in the delisting arrangement period, the Company will not plan or implement major asset restructurings.
-
Investors, securities companies, and other market participants are requested to promptly settle businesses such as stock pledge repurchase, agreed repurchase, margin financing, and securities lending before the stock delisting.
-
For judicial freezing businesses that expire after the stock delisting and before the initial registration period of the delisting board managed by the National Equities Exchange and Quotations Co., Ltd. (NEEQ) on behalf of the NEEQ system for the two-network companies and delisted companies (hereinafter referred to as the "Delisting Board"), it is recommended that the competent authorities handle the renewal of freezing procedures in advance through the original assisting execution channels before the stock delisting.